Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention

被引：0
|
作者：
Kreutz, Reinhold [1 ,2 ,3 ,4 ]
机构：
[1] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Charitepl 1, D-10117 Berlin, Germany
[2] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany
[3] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany
[4] Berlin Inst Hlth, Charite Campus Mitte, Charitepl 1, D-10117 Berlin, Germany
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2024年 / 134卷 / 11期
关键词：
VITAMIN-K ANTAGONISTS; RENAL-FUNCTION; OUTCOMES; RISK;
D O I：
10.20452/pamw.16892
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review
    Wing, Sara L.
    Mavrakanas, Thomas A.
    Harel, Ziv
    SEMINARS IN NEPHROLOGY, 2024, 44 (02)
  • [22] NUANCES IN ANTICOAGULATION TREATMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION
    Kobalava, Z. D.
    Shavarov, A. A.
    KARDIOLOGIYA, 2018, 58 (10) : 59 - 70
  • [23] Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease
    Turagam, Mohit K.
    Addepally, Naga S.
    Velagapudi, Poonam
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (10) : 1297 - 1299
  • [24] Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?
    Shahid, Farhan
    Shantsila, Eduard
    Lip, Gregory Y. H.
    CHEST, 2016, 149 (04) : 891 - 892
  • [25] Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation
    Garcia, David A.
    THROMBOSIS RESEARCH, 2012, 129 (01) : 9 - 16
  • [26] Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation
    Cho, Min Soo
    Choi, Hyung Oh
    Hwang, Ki Won
    Kim, Jun
    Nam, Gi-Byoung
    Choi, Kee-Joon
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [27] Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation
    Min Soo Cho
    Hyung Oh Choi
    Ki Won Hwang
    Jun Kim
    Gi-Byoung Nam
    Kee-Joon Choi
    BMC Cardiovascular Disorders, 23
  • [28] Oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
    Prkacin, Ingrid
    Cavric, Gordana
    Adam, Visnja Nesek
    Balenovic, Diana
    Horvat, Ivan
    Dobrota, Vesna Dermanovic
    Radocaj, Tomislav
    SIGNA VITAE, 2016, 11 : 41 - 43
  • [29] Anticoagulation control in atrial fibrillation patients with chronic kidney disease receiving warfarin for stroke prevention: The west Birmingham AF project
    Zulkifly, H. H.
    Lip, G. Y. H.
    Lane, D. A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 17 - 17
  • [30] Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
    Kefer, Joelle
    Tzikas, Apostolos
    Freixa, Xavier
    Shakir, Samera
    Gafoor, Sameer
    Nielsen-Kudsk, Jens Erik
    Berti, Sergio
    Santoro, Gennaro
    Aminian, Adel
    Landmesser, Ulf
    Nietlispach, Fabian
    Ibrahim, Reda
    Danna, Paolo Luciano
    Benit, Edouard
    Budts, Werner
    Stammen, Francis
    De Potter, Tom
    Tichelbaecker, Tobias
    Gloekler, Steffen
    Kanagaratnam, Prapa
    Costa, Marco
    Cruz-Gonzalez, Ignacio
    Sievert, Horst
    Schillinger, Wolfgang
    Park, Jai-Wun
    Meier, Bernhard
    Omran, Heyder
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 335 - 340
12345